Prevalence and distribution pattern of AmpC β-lactamases in ESBL producing clinical isolates of Klebsiella spp. in parts of Assam, India

The production of extended-spectrum β-lactamases (ESBLs) and AmpC β-lactamases is the most common explanation of multidrug resistance in clinical isolates of Klebsiella spp. In the present study, a total of 160 isolates of Klebsiella spp. were procured from the DBT-NER project with ethical clearance...

Full description

Saved in:
Bibliographic Details
Published in:World journal of microbiology & biotechnology 2024-01, Vol.40 (1), p.38-38, Article 38
Main Authors: Gogoi, Indrani, Saikia, Shyamalima, Sharma, Mohan, Onyango, Amos Oloo, Puzari, Minakshi, Chetia, Pankaj
Format: Article
Language:English
Subjects:
Anti-Bacterial Agents - pharmacology
Applied Microbiology
Bacterial Proteins - genetics
beta-Lactamases - genetics
Biochemistry
Biomedical and Life Sciences
Biotechnology
Clinical isolates
Drug resistance
Environmental Engineering/Biotechnology
Genotype & phenotype
Genotypes
Humans
Klebsiella
Klebsiella - genetics
Klebsiella pneumoniae - genetics
Life Sciences
Microbial Sensitivity Tests
Microbiology
Multidrug resistance
Polymerase chain reaction
Prevalence
Public health
β Lactamase
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c326t-2f083d98d03e1d0287b144ff719981a5d381885eb893caa74f137f779ade15df3
container_end_page 38
container_issue 1
container_start_page 38
container_title World journal of microbiology & biotechnology
container_volume 40
creator Gogoi, Indrani
Saikia, Shyamalima
Sharma, Mohan
Onyango, Amos Oloo
Puzari, Minakshi
Chetia, Pankaj
description The production of extended-spectrum β-lactamases (ESBLs) and AmpC β-lactamases is the most common explanation of multidrug resistance in clinical isolates of Klebsiella spp. In the present study, a total of 160 isolates of Klebsiella spp. were procured from the DBT-NER project with ethical clearance no. DU/Dib/ECBHR(Human)/2021-22/02). These were collected from various health settings of Assam and identified as drug-resistant. The isolates were screened for antibiotic susceptibility and phenotypic tests were performed on multidrug resistant isolates to confirm ESBL and AmpC β-lactamases production. The distribution pattern of ESBL and AmpC β-lactamase genotype was investigated by polymerase chain reaction (PCR). The results showed that among 107 multidrug-resistant (MDR) isolates of Klebsiella spp., 67.28% of isolates were ESBL producers and 56.07% were potential AmpC producers. The PCR results revealed that bla CTX−M was the most prevalent ESBL genotype. Among the ESBL producers, 11.11% of isolates showed co-occurrence with plasmid-mediated AmpC β lactamases genotype which indicated the high prevalence of ESBL and AmpC co-producers in K. pneumoniae and K. oxytoca , suggesting the possibility of serious public health concerns. Therefore, it is crucial to regularly monitor the spread of multidrug resistance among clinical isolates.
doi_str_mv 10.1007/s11274-023-03846-3
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2902945924</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2902945924</sourcerecordid><originalsourceid>FETCH-LOGICAL-c326t-2f083d98d03e1d0287b144ff719981a5d381885eb893caa74f137f779ade15df3</originalsourceid><addsrcrecordid>eNp9kU1uFDEQhS0EIkPgAiyQJTYs6OCf7rG9nIwSiDISSMDaqvZP5Kjb3dhuJI7AdXIQzhRPJiQSC1Ylq7736skPodeUnFBCxIdMKRNtQxhvCJftuuFP0Ip2oj6VYE_RiqhONVwpfoRe5HxNSJUp_hwdcUnWjAmxQr-_JPcTBheNwxAttiGXFPqlhCniGUpxKeLJ4804b_Gfm2YAU2CE7DIOEZ99Pd3hOU12MSFeYTOEGAwMOORpgFKZqrwcXJ-DGwbAeZ5P9rIZUrnbbXKG8T2-iDbAS_TMw5Ddq_t5jL6fn33bfmp2nz9ebDe7xnC2Lg3zRHKrpCXcUUuYFD1tW-8FVUpS6CyXVMrO9VJxAyBaT7nwQiiwjnbW82P07uBbc_9YXC56DNns80U3LVkzRZhqO8Xair79B72elhRrOs2kqkT99D3FDpRJU87JeT2nMEL6pSnR-6L0oShdi9J3RWleRW_urZd-dPZB8reZCvADkOsqXrn0ePs_trc0pJ6N</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2899248464</pqid></control><display><type>article</type><title>Prevalence and distribution pattern of AmpC β-lactamases in ESBL producing clinical isolates of Klebsiella spp. in parts of Assam, India</title><source>ABI/INFORM Global (ProQuest)</source><source>Springer Nature</source><creator>Gogoi, Indrani ; Saikia, Shyamalima ; Sharma, Mohan ; Onyango, Amos Oloo ; Puzari, Minakshi ; Chetia, Pankaj</creator><creatorcontrib>Gogoi, Indrani ; Saikia, Shyamalima ; Sharma, Mohan ; Onyango, Amos Oloo ; Puzari, Minakshi ; Chetia, Pankaj</creatorcontrib><description>The production of extended-spectrum β-lactamases (ESBLs) and AmpC β-lactamases is the most common explanation of multidrug resistance in clinical isolates of Klebsiella spp. In the present study, a total of 160 isolates of Klebsiella spp. were procured from the DBT-NER project with ethical clearance no. DU/Dib/ECBHR(Human)/2021-22/02). These were collected from various health settings of Assam and identified as drug-resistant. The isolates were screened for antibiotic susceptibility and phenotypic tests were performed on multidrug resistant isolates to confirm ESBL and AmpC β-lactamases production. The distribution pattern of ESBL and AmpC β-lactamase genotype was investigated by polymerase chain reaction (PCR). The results showed that among 107 multidrug-resistant (MDR) isolates of Klebsiella spp., 67.28% of isolates were ESBL producers and 56.07% were potential AmpC producers. The PCR results revealed that bla CTX−M was the most prevalent ESBL genotype. Among the ESBL producers, 11.11% of isolates showed co-occurrence with plasmid-mediated AmpC β lactamases genotype which indicated the high prevalence of ESBL and AmpC co-producers in K. pneumoniae and K. oxytoca , suggesting the possibility of serious public health concerns. Therefore, it is crucial to regularly monitor the spread of multidrug resistance among clinical isolates.</description><identifier>ISSN: 0959-3993</identifier><identifier>EISSN: 1573-0972</identifier><identifier>DOI: 10.1007/s11274-023-03846-3</identifier><identifier>PMID: 38062277</identifier><language>eng</language><publisher>Dordrecht: Springer Netherlands</publisher><subject>Anti-Bacterial Agents - pharmacology ; Applied Microbiology ; Bacterial Proteins - genetics ; beta-Lactamases - genetics ; Biochemistry ; Biomedical and Life Sciences ; Biotechnology ; Clinical isolates ; Drug resistance ; Environmental Engineering/Biotechnology ; Genotype &amp; phenotype ; Genotypes ; Humans ; Klebsiella ; Klebsiella - genetics ; Klebsiella pneumoniae - genetics ; Life Sciences ; Microbial Sensitivity Tests ; Microbiology ; Multidrug resistance ; Polymerase chain reaction ; Prevalence ; Public health ; β Lactamase</subject><ispartof>World journal of microbiology &amp; biotechnology, 2024-01, Vol.40 (1), p.38-38, Article 38</ispartof><rights>The Author(s), under exclusive licence to Springer Nature B.V. 2023. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.</rights><rights>2023. The Author(s), under exclusive licence to Springer Nature B.V.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c326t-2f083d98d03e1d0287b144ff719981a5d381885eb893caa74f137f779ade15df3</cites><orcidid>0000-0003-4202-5794</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2899248464/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$H</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2899248464?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,780,784,11688,27924,27925,36060,36061,44363,74895</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/38062277$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gogoi, Indrani</creatorcontrib><creatorcontrib>Saikia, Shyamalima</creatorcontrib><creatorcontrib>Sharma, Mohan</creatorcontrib><creatorcontrib>Onyango, Amos Oloo</creatorcontrib><creatorcontrib>Puzari, Minakshi</creatorcontrib><creatorcontrib>Chetia, Pankaj</creatorcontrib><title>Prevalence and distribution pattern of AmpC β-lactamases in ESBL producing clinical isolates of Klebsiella spp. in parts of Assam, India</title><title>World journal of microbiology &amp; biotechnology</title><addtitle>World J Microbiol Biotechnol</addtitle><addtitle>World J Microbiol Biotechnol</addtitle><description>The production of extended-spectrum β-lactamases (ESBLs) and AmpC β-lactamases is the most common explanation of multidrug resistance in clinical isolates of Klebsiella spp. In the present study, a total of 160 isolates of Klebsiella spp. were procured from the DBT-NER project with ethical clearance no. DU/Dib/ECBHR(Human)/2021-22/02). These were collected from various health settings of Assam and identified as drug-resistant. The isolates were screened for antibiotic susceptibility and phenotypic tests were performed on multidrug resistant isolates to confirm ESBL and AmpC β-lactamases production. The distribution pattern of ESBL and AmpC β-lactamase genotype was investigated by polymerase chain reaction (PCR). The results showed that among 107 multidrug-resistant (MDR) isolates of Klebsiella spp., 67.28% of isolates were ESBL producers and 56.07% were potential AmpC producers. The PCR results revealed that bla CTX−M was the most prevalent ESBL genotype. Among the ESBL producers, 11.11% of isolates showed co-occurrence with plasmid-mediated AmpC β lactamases genotype which indicated the high prevalence of ESBL and AmpC co-producers in K. pneumoniae and K. oxytoca , suggesting the possibility of serious public health concerns. Therefore, it is crucial to regularly monitor the spread of multidrug resistance among clinical isolates.</description><subject>Anti-Bacterial Agents - pharmacology</subject><subject>Applied Microbiology</subject><subject>Bacterial Proteins - genetics</subject><subject>beta-Lactamases - genetics</subject><subject>Biochemistry</subject><subject>Biomedical and Life Sciences</subject><subject>Biotechnology</subject><subject>Clinical isolates</subject><subject>Drug resistance</subject><subject>Environmental Engineering/Biotechnology</subject><subject>Genotype &amp; phenotype</subject><subject>Genotypes</subject><subject>Humans</subject><subject>Klebsiella</subject><subject>Klebsiella - genetics</subject><subject>Klebsiella pneumoniae - genetics</subject><subject>Life Sciences</subject><subject>Microbial Sensitivity Tests</subject><subject>Microbiology</subject><subject>Multidrug resistance</subject><subject>Polymerase chain reaction</subject><subject>Prevalence</subject><subject>Public health</subject><subject>β Lactamase</subject><issn>0959-3993</issn><issn>1573-0972</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>M0C</sourceid><recordid>eNp9kU1uFDEQhS0EIkPgAiyQJTYs6OCf7rG9nIwSiDISSMDaqvZP5Kjb3dhuJI7AdXIQzhRPJiQSC1Ylq7736skPodeUnFBCxIdMKRNtQxhvCJftuuFP0Ip2oj6VYE_RiqhONVwpfoRe5HxNSJUp_hwdcUnWjAmxQr-_JPcTBheNwxAttiGXFPqlhCniGUpxKeLJ4804b_Gfm2YAU2CE7DIOEZ99Pd3hOU12MSFeYTOEGAwMOORpgFKZqrwcXJ-DGwbAeZ5P9rIZUrnbbXKG8T2-iDbAS_TMw5Ddq_t5jL6fn33bfmp2nz9ebDe7xnC2Lg3zRHKrpCXcUUuYFD1tW-8FVUpS6CyXVMrO9VJxAyBaT7nwQiiwjnbW82P07uBbc_9YXC56DNns80U3LVkzRZhqO8Xair79B72elhRrOs2kqkT99D3FDpRJU87JeT2nMEL6pSnR-6L0oShdi9J3RWleRW_urZd-dPZB8reZCvADkOsqXrn0ePs_trc0pJ6N</recordid><startdate>20240101</startdate><enddate>20240101</enddate><creator>Gogoi, Indrani</creator><creator>Saikia, Shyamalima</creator><creator>Sharma, Mohan</creator><creator>Onyango, Amos Oloo</creator><creator>Puzari, Minakshi</creator><creator>Chetia, Pankaj</creator><general>Springer Netherlands</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QL</scope><scope>7T7</scope><scope>7TB</scope><scope>7TK</scope><scope>7U5</scope><scope>7U9</scope><scope>7WY</scope><scope>7WZ</scope><scope>7X7</scope><scope>7XB</scope><scope>87Z</scope><scope>88A</scope><scope>88E</scope><scope>88I</scope><scope>8AO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8FL</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BEZIV</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FRNLG</scope><scope>FYUFA</scope><scope>F~G</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K60</scope><scope>K6~</scope><scope>K9.</scope><scope>L.-</scope><scope>L7M</scope><scope>LK8</scope><scope>M0C</scope><scope>M0S</scope><scope>M1P</scope><scope>M2P</scope><scope>M7N</scope><scope>M7P</scope><scope>P64</scope><scope>PQBIZ</scope><scope>PQBZA</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-4202-5794</orcidid></search><sort><creationdate>20240101</creationdate><title>Prevalence and distribution pattern of AmpC β-lactamases in ESBL producing clinical isolates of Klebsiella spp. in parts of Assam, India</title><author>Gogoi, Indrani ; Saikia, Shyamalima ; Sharma, Mohan ; Onyango, Amos Oloo ; Puzari, Minakshi ; Chetia, Pankaj</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c326t-2f083d98d03e1d0287b144ff719981a5d381885eb893caa74f137f779ade15df3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Anti-Bacterial Agents - pharmacology</topic><topic>Applied Microbiology</topic><topic>Bacterial Proteins - genetics</topic><topic>beta-Lactamases - genetics</topic><topic>Biochemistry</topic><topic>Biomedical and Life Sciences</topic><topic>Biotechnology</topic><topic>Clinical isolates</topic><topic>Drug resistance</topic><topic>Environmental Engineering/Biotechnology</topic><topic>Genotype &amp; phenotype</topic><topic>Genotypes</topic><topic>Humans</topic><topic>Klebsiella</topic><topic>Klebsiella - genetics</topic><topic>Klebsiella pneumoniae - genetics</topic><topic>Life Sciences</topic><topic>Microbial Sensitivity Tests</topic><topic>Microbiology</topic><topic>Multidrug resistance</topic><topic>Polymerase chain reaction</topic><topic>Prevalence</topic><topic>Public health</topic><topic>β Lactamase</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gogoi, Indrani</creatorcontrib><creatorcontrib>Saikia, Shyamalima</creatorcontrib><creatorcontrib>Sharma, Mohan</creatorcontrib><creatorcontrib>Onyango, Amos Oloo</creatorcontrib><creatorcontrib>Puzari, Minakshi</creatorcontrib><creatorcontrib>Chetia, Pankaj</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Mechanical &amp; Transportation Engineering Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Solid State and Superconductivity Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>ABI/INFORM Collection</collection><collection>ABI/INFORM Global (PDF only)</collection><collection>ProQuest Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ABI/INFORM Collection</collection><collection>Biology Database (Alumni Edition)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Science Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ABI/INFORM Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>Business Premium Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Business Premium Collection (Alumni)</collection><collection>Health Research Premium Collection</collection><collection>ABI/INFORM Global (Corporate)</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Business Collection (Alumni Edition)</collection><collection>ProQuest Business Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>ABI/INFORM Professional Advanced</collection><collection>Advanced Technologies Database with Aerospace</collection><collection>ProQuest Biological Science Collection</collection><collection>ABI/INFORM Global (ProQuest)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>ProQuest Science Journals</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>One Business (ProQuest)</collection><collection>ProQuest One Business (Alumni)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>World journal of microbiology &amp; biotechnology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gogoi, Indrani</au><au>Saikia, Shyamalima</au><au>Sharma, Mohan</au><au>Onyango, Amos Oloo</au><au>Puzari, Minakshi</au><au>Chetia, Pankaj</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Prevalence and distribution pattern of AmpC β-lactamases in ESBL producing clinical isolates of Klebsiella spp. in parts of Assam, India</atitle><jtitle>World journal of microbiology &amp; biotechnology</jtitle><stitle>World J Microbiol Biotechnol</stitle><addtitle>World J Microbiol Biotechnol</addtitle><date>2024-01-01</date><risdate>2024</risdate><volume>40</volume><issue>1</issue><spage>38</spage><epage>38</epage><pages>38-38</pages><artnum>38</artnum><issn>0959-3993</issn><eissn>1573-0972</eissn><abstract>The production of extended-spectrum β-lactamases (ESBLs) and AmpC β-lactamases is the most common explanation of multidrug resistance in clinical isolates of Klebsiella spp. In the present study, a total of 160 isolates of Klebsiella spp. were procured from the DBT-NER project with ethical clearance no. DU/Dib/ECBHR(Human)/2021-22/02). These were collected from various health settings of Assam and identified as drug-resistant. The isolates were screened for antibiotic susceptibility and phenotypic tests were performed on multidrug resistant isolates to confirm ESBL and AmpC β-lactamases production. The distribution pattern of ESBL and AmpC β-lactamase genotype was investigated by polymerase chain reaction (PCR). The results showed that among 107 multidrug-resistant (MDR) isolates of Klebsiella spp., 67.28% of isolates were ESBL producers and 56.07% were potential AmpC producers. The PCR results revealed that bla CTX−M was the most prevalent ESBL genotype. Among the ESBL producers, 11.11% of isolates showed co-occurrence with plasmid-mediated AmpC β lactamases genotype which indicated the high prevalence of ESBL and AmpC co-producers in K. pneumoniae and K. oxytoca , suggesting the possibility of serious public health concerns. Therefore, it is crucial to regularly monitor the spread of multidrug resistance among clinical isolates.</abstract><cop>Dordrecht</cop><pub>Springer Netherlands</pub><pmid>38062277</pmid><doi>10.1007/s11274-023-03846-3</doi><tpages>1</tpages><orcidid>https://orcid.org/0000-0003-4202-5794</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0959-3993
ispartof World journal of microbiology & biotechnology, 2024-01, Vol.40 (1), p.38-38, Article 38
issn 0959-3993
1573-0972
language eng
recordid cdi_proquest_miscellaneous_2902945924
source ABI/INFORM Global (ProQuest); Springer Nature
subjects Anti-Bacterial Agents - pharmacology
Applied Microbiology
Bacterial Proteins - genetics
beta-Lactamases - genetics
Biochemistry
Biomedical and Life Sciences
Biotechnology
Clinical isolates
Drug resistance
Environmental Engineering/Biotechnology
Genotype & phenotype
Genotypes
Humans
Klebsiella
Klebsiella - genetics
Klebsiella pneumoniae - genetics
Life Sciences
Microbial Sensitivity Tests
Microbiology
Multidrug resistance
Polymerase chain reaction
Prevalence
Public health
β Lactamase
title Prevalence and distribution pattern of AmpC β-lactamases in ESBL producing clinical isolates of Klebsiella spp. in parts of Assam, India
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T07%3A53%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Prevalence%20and%20distribution%20pattern%20of%20AmpC%20%CE%B2-lactamases%20in%20ESBL%20producing%20clinical%20isolates%20of%20Klebsiella%20spp.%20in%20parts%20of%20Assam,%20India&rft.jtitle=World%20journal%20of%20microbiology%20&%20biotechnology&rft.au=Gogoi,%20Indrani&rft.date=2024-01-01&rft.volume=40&rft.issue=1&rft.spage=38&rft.epage=38&rft.pages=38-38&rft.artnum=38&rft.issn=0959-3993&rft.eissn=1573-0972&rft_id=info:doi/10.1007/s11274-023-03846-3&rft_dat=%3Cproquest_cross%3E2902945924%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c326t-2f083d98d03e1d0287b144ff719981a5d381885eb893caa74f137f779ade15df3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2899248464&rft_id=info:pmid/38062277&rfr_iscdi=true